Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Farzana Virani

Optometrist Kennesaw, GA Doctor of Optometry

NPI 1356481428 CMS profile 243403

1415 Wooten Lake Rd Nw Ste 100, Kennesaw, GA 30144

Open in the dashboard

General payments

$9,690

154 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Farzana Virani of Kennesaw, GA is reported in the CMS Open Payments database as having received $9,690 across 154 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,178 50
2024 General $1,854 26
2023 General $469 9
2022 General $993 25
2021 General $843 17
2020 General $460 16
2019 General $1,893 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Farzana Virani
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Farzana Virani were reported at $3,178. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Farzana Virani Optometrist median Middle half National median
2019 $1,893 $159 $67–$371 $163
2020 $460 $72 $29–$165 $114
2021 $843 $125 $46–$292 $132
2022 $993 $162 $66–$374 $149
2023 $469 $177 $72–$406 $160
2024 $1,854 $188 $77–$427 $164
2025 $3,178 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $1,613 29 payments
  2. Johnson & Johnson Surgical Vision, Inc. $1,484 3 payments
  3. Bausch & Lomb Americas Inc. $1,250 25 payments
  4. CooperVision Inc. $1,241 21 payments
  5. Harrow Eye, LLC $888 19 payments
  6. Johnson & Johnson Vision Care, Inc. $448 8 payments
  7. Glaukos Corporation $404 3 payments
  8. Bausch & Lomb, a division of Bausch Health US, LLC $386 8 payments
  9. Tarsus Pharmaceuticals, Inc. $334 6 payments
  10. Novartis Pharmaceuticals Corporation $239 6 payments
  11. Other $1,403 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,166 150 payments
  2. Travel and Lodging $1,486 2 payments
  3. Gift $39 2 payments
Products named General payments · program years 2019–2025
  1. Tecnis Symphony IOL $1,441 2 payments
  2. Tecnis Symphony Toric IOL $1,441 2 payments
  3. Tecnis 3-piece IOL $1,441 2 payments
  4. Tecnis 1-piece IOL $1,441 2 payments
  5. VEVYE $888 19 payments
  6. INFUSE $636 16 payments
  7. Clariti Contact Lens $492 7 payments
  8. MyDay Contact Lens $441 10 payments
  9. Precision 1 $409 15 payments
  10. XIIDRA $364 7 payments
  11. Other $5,503 89 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record